The Claim
In adults with type 2 diabetes and chronic kidney disease, once-weekly subcutaneous semaglutide 1.0 mg reduces the risk of a composite kidney outcome—defined as persistent ≥50% eGFR decline, kidney failure, or death from kidney or cardiovascular causes—by 24% compared to placebo over a median follow-up of 3.4 years, independent of baseline mineralocorticoid receptor antagonist use.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In adults with type 2 diabetes and kidney disease, a weekly injection of semaglutide at 1.0 mg lowers the combined risk of severe kidney function decline, kidney failure, or death from kidney or heart causes by 24% compared to a placebo over about 3.4 years, regardless of whether they were already taking mineralocorticoid receptor antagonists.
See the scientific wording
In adults with type 2 diabetes and chronic kidney disease, once-weekly subcutaneous semaglutide 1.0 mg reduces the risk of a composite kidney outcome—defined as persistent ≥50% eGFR decline, kidney failure, or death from kidney or cardiovascular causes—by 24% compared to placebo over a median follow-up of 3.4 years, independent of baseline mineralocorticoid receptor antagonist use.
Semaglutide activates receptors in the kidneys that lower blood pressure inside the filtering units, reduce excess sugar and fat in the blood, and decrease the workload on kidney cells, which prevents damage and loss of kidney function over time.
What the research says
1 studyThis study found that a weekly injection called semaglutide helps protect the kidneys and heart in people with type 2 diabetes and kidney disease, even if they’re already taking another medicine for their kidneys. It lowered their risk of serious kidney or heart problems by about 20–50%, no matter what other meds they were on.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.